Search clinical trials for: UDCA

Total 105 results

Dr. Falk Pharma GmbH

Completed

Pharmacokinetic Investigation of UDCA in Bile and Serum

Healthy

Netherlands
Beijing Trendful Kangjian Medical Information Consulting...

Completed

Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBC

Cholestatic Liver Disease

China
Nanjing Chia-tai Tianqing Pharmaceutical

Recruiting

Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis

Primary Biliary Cholangitis

China
Daewoong Pharmaceutical Co. LTD.

Completed

A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects

Healthy
Sheffield Teaching Hospitals NHS Foundation Trust
JP Moulton Charitable Foundation; PRO.MED.CS Praha a.s.; Clinical Trials Research...

Completed

Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study

Parkinson's Disease

United Kingdom
Fuzhou General Hospital

Active, not recruiting

Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis
Xijing Hospital of Digestive Diseases

Unknown

Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
Xijing Hospital of Digestive Diseases

Unknown

Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cirrhosis

China
University of Tennessee
University of Colorado, Denver; Baylor College of Medicine; Children's Hospital... and other collaborators

Completed

Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

United States
University of Colorado, Denver
University of Colorado School of Dental Medicine

Completed

Prevention of Enamel Demineralization by Use of K18-smooth Surface Sealant (K18)

Dental Caries

United States
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

Gastric Cancer

Korea, Republic of
MinaPharm Pharmaceuticals

Recruiting

Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients (URSO-003)

Chronic Liver Disease

Egypt
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis

China
HighTide Biopharma Pty Ltd

Completed

Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis (PRONTO-PBC)

Biliary Tract Diseases | Cholangitis | Cholestasis | Primary Biliary Cholangitis | Primary Biliary Cirrhosis | Bile Duct Stricture

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Active, not recruiting

Application of PDCA Circular Management to Improve Critical Thinking Skills of ICU Nurses Within Five Years of Employment

PDCA Circular Management

China
Ethan Weinberg
American Association for the Study of Liver Diseases; Meridian Bioscience,...

Terminated

Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis

Hepatic Sarcoidosis, Elevated Alkaline Phosphatase

United States
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Transplanting Lungs From Uncontrolled Donation After Circulatory Death

Lung Transplantation

United States
National Institute of Diabetes and Digestive and...

Terminated

Trial of High-dose Urso in Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

United States
Mirum Pharmaceuticals, Inc.

Completed

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis (CLARITY)

Primary Biliary Cirrhosis | PBC

United States, United Kingdom, Canada
University Clinical Centre of Kosova
University of Zagreb

Unknown

The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice

Obstructive Jaundice

Serbia
US Department of Veterans Affairs

Completed

Clinical Studies on Bile Acids in Barrett's Esophagus

Gastroesophageal Reflux Disease

United States
Mirum Pharmaceuticals, Inc.

Completed

Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)

CTX

United States, Brazil
Taipei Veterans General Hospital, Taiwan

Unknown

Cholestatic Drug-induced Liver Injury (DILI)

Hepatitis, Toxic

Taiwan
Peking Union Medical College Hospital

Recruiting

Clinical Research of UCDA Reducing Medication Regimen in Stable PBC (UCDA PBC)

Primary Biliary Cholangitis

China
Sahlgrenska University Hospital, Sweden

Completed

Ursodeoxycholic Acid in Bariatric Surgery

Non-alcoholic Fatty Liver Disease | Morbid Obesity
Yale University

Not yet recruiting

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness
University of Edinburgh
Ferring Pharmaceuticals; University of Nottingham; University of Birmingham

Unknown

A Clinical Trial to Evaluate Dichloroacetate (DCA) as a Treatment for Endometriosis-associated Pain (EPiC)

Endometriosis

United Kingdom
University of Alberta
Capital Health, Canada

Completed

The Safety and Efficacy of DCA for the Treatment of Brain Cancer

Malignant Gliomas, Glioblastoma Multiforme

Canada
University of Florida

No longer available

Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Expanded Access (CLA)

Mitochondrial Enzyme Deficiencies

United States
University of Florida
National Institutes of Health (NIH)

Completed

Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors

Glioblastoma | Brain Tumor

United States
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin

Diabetes Mellitus

China
Children's Hospital of Fudan University

Withdrawn

BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases

Cholestasis, Intrahepatic | Hereditary Diseases
Beijing Ditan Hospital

Recruiting

UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease

COVID-19 Infection

China
Dr. Falk Pharma GmbH

Completed

Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

Germany
Jonsson Comprehensive Cancer Center

Terminated

Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)

Lung Cancer | Metastatic Breast Cancer

United States
Tanta University

Recruiting

Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Egypt
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis

China
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cirrhosis

China
National Cancer Institute (NCI)

Completed

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

Barrett Esophagus | Esophageal Carcinoma

United States
Sahlgrenska University Hospital, Sweden

Not yet recruiting

Transplantation of Uncontrolled DCD Kidneys REconditioned by a Novel Ex-VIVo Perfusion MEthod (REVIVEME)

End-Stage Kidney Disease
University of Alberta
Imperial College London

Completed

Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension

Pulmonary Hypertension (Idiopathic, Familial or Anorexigen-associated)

Canada, United Kingdom
Assistance Publique - Hôpitaux de Paris

Recruiting

Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy (BEZASCLER)

Primary Sclerosing Cholangitis | Cholestasis

France
Han Ying

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

Primary Biliary Cholangitis

China
Robert Chunhua Zhao, MD, PhD
Peking Union Medical College Hospital

Unknown

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis (MSCsTreatPBC)

Primary Biliary Cirrhosis

China
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
Vanderbilt University Medical Center

Terminated

Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans

Glucose Intolerance | Gastric Bypass Surgery

United States
BioCis Pharma Ltd

Completed

Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis

Atopic Dermatitis

Finland
Oregon Health and Science University
Huntington Study Group; Huntington Society of Canada

Unknown

Ursodiol in Huntington's Disease (UDCA-HD)

Huntington Disease

United States
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

Primary Biliary Cholangitis

China
Robin Goland, MD
Juvenile Diabetes Research Foundation

Unknown

Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes

Type 1 Diabetes

United States

Search clinical trials for: UDCA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations